期刊文献+

肝组织免疫组化病人104例远期随访调查 被引量:1

Long-term follow up 104 patients who had been diagnosed by liver tissue immunohistochemical stain assay
暂未订购
导出
摘要 目的 为了解病毒性肝炎患者肝组织不同免疫组化与远期预后关系。方法 采用回顾性前瞻性方法随访 6~ 8年前经肝穿病理组织学、免疫组化诊断的 132例肝病住院患者远期转归与肝组织免疫组化的关系。内容包括症状、体征、肝功能、HBVM、肝脾B超等指标。结果 随访到 10 4例中有 4例已死于肝硬化 ,病死率为 3 85 % ;存活 10 0例中 2例 (2 0 0 % )B超显示典型肝硬化改变 ,16例 (16 0 % )B超显示早期肝硬化改变 ,2 6例 (2 6 % )B超显示肝表面欠光滑 ,肝内实质呈弥漫性改变。肝组织HBsAg、HBcAg阳性者 ,ALT较易波动。结论 肝组织中HBsAg、HBcAg阳性者病情易波动 ,对预后影响不明显。 objective To determine the relationship between immunohistochemical stain assay of liver tissue and prognosis of viral hepatitis.Methods 132 patients with chronic hepatitis B diagnosed 6 to 8 years ago by liver biopsy had been followed up by the retrospective and prospective study.The serum hepatitis B virus markers(HBVm)?alpha-fetoprotein(AFP)?Alanine aminotransferase(ALT) and Aspartate aminotransferase(AST)have been detected and B-scan ultrasound of liver and spleen have performed when they stayed at hospital and during follow-up-time,their symptom and physical sign have been recorded simultaneously.Results 4 of 104(3 85%) patients died of cirrhosis;of 100 survival patients,2 patients(2%,2/100) were typical cirrhosis and 16 (16%,16/100) patients were early stage cirrhosis and parenchyma of liver diffuse lesion diagnosed by ultrasound.The serum ALT of patients whose HBcAg and HBsAg were positive in liver tissue was easier fluctuation than those of negative case.Conclusion The status of patients with HBsAg and HBcAg positive in liver tissue is easier fluctuation than those negative,HBsAg and HBcAg positive in liver tissue maybe have no effect on the prognosis of the chronic hepatitis B.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2003年第12期730-731,共2页 Chinese Journal of Practical Internal Medicine
基金 广西自然科学基金资助项目 (98110 3 8)
关键词 肝组织 免疫组化 远期预后 病理组织学 病毒性肝炎 Liver tissue Immunohistochemical Long-term prognosis
  • 相关文献

参考文献1

  • 1骆抗先.肝内病毒状态和免疫应答[A]..乙型肝炎基础与临床:第2版[C].北京:人民卫生出版社,2001,5.117.

同被引文献21

  • 1骆抗先.乙型肝炎基础和临床(第2版)[M].北京:人民卫生出版社,2001.415-435.
  • 2Merican l,Guan R,Amarapuka D,et al. SPECIAL REPORT:Chronic hepatitis B virus infection in Asian countries[J].Journal of Gastroenterology and Hepatology, 2000,15 : 1356.
  • 3Crowley SJ, Tognarini D. Desmond PV, et al. Cost -- effectiveness analysis of lamivudine for the treatment of chronic hepatitis B[J]. Pharmacoeconomics, 2000.17 (5) : 409.
  • 4Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome[J]. Alimentary Pharmacology&Therapeutics,2001,15(4) : 439.
  • 5Groeneweg M, Moerland W. Quero JC, et al. Screening of subclinical hepatic encephalopathy[J].J Hepatol, 2000,32 (5) : 748.
  • 6Park CK, Park SY, Kim ES, et al. Assessment of quality of life and associated factor patients with chronic viral liver disease[J]. Taehan Kan Hakhoe Chi,2003,9(3) : 212.
  • 7Ian M, Gralnek MD, Ron D, et al. Development and evaluation of the liver disease quality of life instrument in persons with advaneed, chronic liver disease the LDQOL 1.0[J]. The Atnerican .Journal of Gastroenterology, 2000,95 ( 12 ) : 3552.
  • 8Giulio Marchesini, Giampaolo Bianhchi, Piero Amodio, et al.Factors associated with poor health--related quality of life of patients with cirrhosis[J]. Gastroenterology, 2001,120 : 170.
  • 9Younossi ZM, Boparai N, Price LL, et al. Assessment of utilities and health--related quality of life in patients with chronic liver disease [J]. The American Journal of Gastroenterology.2001,96(2) : 579.
  • 10潘化平.慢性乙型肝炎患者生存质量的测量与评价[J].肝脏,2001,6(2):86-88. 被引量:12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部